Literature DB >> 14580740

Procalcitonin serum levels after out-of-hospital cardiac arrest.

Michael Fries1, Dagmar Kunz, Axel M Gressner, Rolf Rossaint, Ralf Kuhlen.   

Abstract

The time course of Procalcitonin (PCT) serum levels was assessed in cardiac arrest survivors and compared with S-100 serum levels concerning their predictive values for neurological outcome. PCT and S-100 serum levels were analyzed serially on admission and during the following 3 days after hospitalization in 23 patients successfully resuscitated from out-of-hospital cardiac arrest. At day 14 patients were divided into groups according to the Glasgow-Outcome-Scale (GOS): one group with bad neurological outcome (GOS 1-3) and one group with good neurological outcome (GOS 4-5). Group comparisons were performed with the Mann-Whitney U-Test. The diagnostic performance of PCT and S-100 levels was analyzed using receiver operating characteristics (ROC). Patients with a bad neurological outcome had significantly higher S-100 levels than those with a good neurological outcome at all investigated time points and significantly elevated PCT levels at days 1-3. Highest levels for S-100 were found immediately after hospitalization (3.4 +/- 3.8 vs. 0.7 +/- 0.3 microg/l, P=0.003), and for PCT at day 1 (37 +/- 103 vs. 0.2 +/- 0.2 microg/l, P=0.0002). The results show that PCT serum levels are possibly elevated in patients with bad neurological outcome after cardiac arrest, without signs of severe infection or concomitant sepsis. Based on this observation, studies on larger numbers of patients should prove the predictive value of PCT in those patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580740     DOI: 10.1016/s0300-9572(03)00164-3

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  22 in total

Review 1.  [Neuromonitoring with S-100 protein in the intensive care unit].

Authors:  M Fries; J Bickenbach; S Beckers; D Henzler; R Rossaint; R Kuhlen
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

2.  Prediction of neurological outcome after cardiac arrest: is serum procalcitonin the future?

Authors:  Nicolas Mongardon; Stéphane Legriel; Virginie Lemiale; Alain Cariou
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

3.  Procalcitonin in hypoxic brain damage.

Authors:  Aisha Lateef; S M Khoo; K H Lee
Journal:  Intensive Care Med       Date:  2005-01-21       Impact factor: 17.440

4.  Effects of volumetric vs. pressure-guided fluid therapy on postoperative inflammatory response: a prospective, randomized clinical trial.

Authors:  Tamas Szakmany; Ildiko Toth; Zsolt Kovacs; Tamas Leiner; Andras Mikor; Tamas Koszegi; Zsolt Molnar
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

5.  Mild hypothermia alone or in combination with anesthetic post-conditioning reduces expression of inflammatory cytokines in the cerebral cortex of pigs after cardiopulmonary resuscitation.

Authors:  Patrick Meybohm; Matthias Gruenewald; Kai D Zacharowski; Martin Albrecht; Ralph Lucius; Nikola Fösel; Johannes Hensler; Karina Zitta; Berthold Bein
Journal:  Crit Care       Date:  2010-02-16       Impact factor: 9.097

6.  Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Carl Muroi; Johanna B Lemb; Michael Hugelshofer; Martin Seule; David Bellut; Emanuela Keller
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

7.  Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.

Authors:  Nicolas Mongardon; Virginie Lemiale; Sébastien Perbet; Florence Dumas; Stéphane Legriel; Sylvie Guérin; Julien Charpentier; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Intensive Care Med       Date:  2009-10-21       Impact factor: 17.440

Review 8.  Brain resuscitation in the drowning victim.

Authors:  Alexis A Topjian; Robert A Berg; Joost J L M Bierens; Christine M Branche; Robert S Clark; Hans Friberg; Cornelia W E Hoedemaekers; Michael Holzer; Laurence M Katz; Johannes T A Knape; Patrick M Kochanek; Vinay Nadkarni; Johannes G van der Hoeven; David S Warner
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

9.  Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients.

Authors:  Hiromi Hayashida; Tadashi Kaneko; Shunji Kasaoka; Chiyomi Oshima; Takashi Miyauchi; Motoki Fujita; Yasutaka Oda; Ryosuke Tsuruta; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

10.  Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.

Authors:  Martin Abild Stengaard Meyer; Sebastian Wiberg; Johannes Grand; Anna Sina Pettersson Meyer; Laust Emil Roelsgaard Obling; Martin Frydland; Jakob Hartvig Thomsen; Jakob Josiassen; Jacob Eifer Møller; Jesper Kjaergaard; Christian Hassager
Journal:  Circulation       Date:  2021-03-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.